scholarly journals A Qualitative Comparative Analysis of Combined State Health Policies Related to Human Papillomavirus Vaccine Uptake in the United States

2018 ◽  
Vol 108 (4) ◽  
pp. 493-499 ◽  
Author(s):  
Megan C. Roberts ◽  
Taylor Murphy ◽  
Jennifer L. Moss ◽  
Christopher W. Wheldon ◽  
Wayne Psek
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
Comparative Analysis ◽  
Qualitative Comparative Analysis ◽  
The United States ◽  
Vaccine Uptake ◽  
Health Policies ◽  
Human Papillomavirus Vaccine ◽  
State Health ◽  
Papillomavirus Vaccine

scholarly journals Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States

Cancer ◽  
2012 ◽  
Vol 119 (7) ◽  
pp. 1386-1392 ◽  
Author(s):  
Tabassum H. Laz ◽  
Mahbubur Rahman ◽  
Abbey B. Berenson
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Vaccine Uptake ◽  
Human Papillomavirus Vaccine ◽  
Papillomavirus Vaccine

scholarly journals Human papillomavirus vaccine initiation among 9–13-year-olds in the United States

2015 ◽  
Vol 2 ◽  
pp. 892-898 ◽  
Author(s):  
Kelly L. Donahue ◽  
Kristin S. Hendrix ◽  
Lynne A. Sturm ◽  
Gregory D. Zimet
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Human Papillomavirus Vaccine ◽  
Vaccine Initiation ◽  
Papillomavirus Vaccine

scholarly journals 962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S29-S29
Author(s):  
Julia Gargano ◽  
Rayleen Lewis ◽  
Hillary Hunt ◽  
Nancy McClung ◽  
Nancy M Bennett ◽  
...  
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
The United States ◽  
Adenocarcinoma In Situ ◽  
Human Papillomavirus Vaccine ◽  
Impact Monitoring ◽  
Vaccine Impact ◽  
Race Ethnicity ◽  
Papillomavirus Vaccine

Abstract Background Since human papillomavirus (HPV) vaccine introduction in the United States in 2006, cervical pre-cancer incidence has declined in young women, but pre-cancer trends have not been reported by race/ethnicity. We evaluated trends in cervical pre-cancers from 2008 to 2016 in non-Hispanic (NH) white, NH black, NH Asian, and Hispanic women identified through active population-based surveillance in the 5-site Human Papillomavirus Vaccine Impact Monitoring Project (HPV-IMPACT). Methods We analyzed data on cervical intraepithelial neoplasia (CIN) grades 2–3 and adenocarcinoma in situ (CIN2+) cases aged 20–39 years. Annual CIN2+ rates per 100,000 women were calculated stratified by race/ethnicity in 5-year age groups, using multiple imputation to account for 10% missing race/ethnicity data. Rates were also calculated using estimated numbers screened for cervical cancer to control for known declines in screening. Trends, evaluated using JoinPoint software, are presented as average annual percentage changes (AAPC) with 95% confidence intervals (CI). Results A total of 18,222 CIN2+ cases (62% NH white, 16% NH black, 16% Hispanic, 6% Asian) were reported from 2008 to 2016. CIN2+ rates among 20–24 year-olds declined significantly in all groups: NH white, AAPC: −14.2 (95% CI: −16.3, −12.1); NH black, AAPC: −15.5 (−19.5, −11.4); Asian, AAPC: −14.8 (−20.5, −8.8); Hispanic, AAPC: −14.3 (−17.9, −10.5). In 25–29 year olds, a significant decline was observed for NH whites only (AAPC: −2.4, [−4.0, −0.8]). No declines were seen in 30–34 or 35–39 year olds. Among screened 20–24 year-olds, significant but smaller declines were observed (AAPC: −9.8 to −8.4); no declines were observed in screened 25–29 year olds or older groups. Conclusion In this evaluation of CIN2+ trends by race/ethnicity during the HPV vaccine era, the significant declines in 20–24 year olds across all groups, including among screened women, is consistent with equitable vaccine impact on CIN2+. Disclosures All Authors: No reported Disclosures.

scholarly journals Early Policy Responses to the Human Papillomavirus Vaccine in the United States, 2006–2010

2014 ◽  
Vol 55 (5) ◽  
pp. 659-664 ◽  
Author(s):  
Miriam J. Laugesen ◽  
Ritesh Mistry ◽  
Kelley A. Carameli ◽  
Kurt M. Ribisl ◽  
Jack Needleman ◽  
...  
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Human Papillomavirus Vaccine ◽  
Policy Responses ◽  
Papillomavirus Vaccine
Sign in / Sign up

Export Citation Format

Share Document